Ginkgo Bioworks Holdings, Inc. (DNA) — Analysis Summary
Ginkgo Bioworks Holdings, Inc. (DNA) has a market cap of $458.59M with year-over-year revenue growth of -25.1%. Net margin stands at -183.8%. The stock trades at a P/E ratio of -1.6.
Key Takeaways
- Revenue changed -25.1% year-over-year
- Net margin of -183.8%
- P/E ratio of -1.6
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, DNA posted revenue growth of -25.1% and trades at a P/E of -1.6.
Ginkgo Bioworks Holdings, Inc. (DNA)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -54.5x — earnings do not cover interest payments
Operating margin at -259.9% — severe operating losses
Net margin at -260.0% — losses exceed revenue (possible one-time charges)
Revenue fell 34.3% vs the prior period.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
485
Headquarters
BOSTON, MA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.